Foundation Medicine’s comprehensive genomic profiling (CGP) assay has been submitted by the company for FDA review as well as for a CMS review in parallel. The FoundationOne CGP assay for cancer can ...
This was a multicenter, retrospective cohort study in adult patients with advanced nonhematologic malignancies who underwent a CGP test. If patients received a targeted therapy for ≥ 6 months, they ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback